Darifenacin Relieves Overactive Bladder

Darifenacin (Enablex®, Novartis) extended-release tablets (7.5 and 15 mg) have been approved for patients with overactive bladder. The product blocks the M3 receptor, which is primarily responsible for bladder muscle contraction; helps lower the number of incontinence episodes; increases the amount of urine the bladder can hold; reduces the frequency of urination episodes; and decreases the pressure associated with the urge to urinate. cialis canadian pharmacy

Darifenacin is not indicated in patients with urinary or gastric retention or with uncontrolled narrow-angle glaucoma.